APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort
The Journals of Gerontology: Series A, glaa131, https://doi.org/10.1093/gerona/glaa131
Published: 26 May 2020
https://academic.oup.com/biomedgerontology/advance-article/doi/10.1093/gerona/glaa131/5843454
https://www.sciencemediacentre.org/expert-reaction-to-study-on-covid-19-and-a-faulty-gene-linked-to-dementia/
Prof Tara Spires-Jones, UK Dementia Research Institute Group Leader and Deputy Director, Centre for Discovery Brain Sciences, The University of Edinburgh
“Using data from over 300,000 people in the UK BioBank, Prof Melzer and colleagues observe
an association between the APOE4 gene and risk of testing positive for COVID-19.
“This study is robustly conducted, and the observation is important and will lead to future research into how APOE4 may influence the risk of contracting COVID-19
or having severe symptoms requiring hospitalisation, where most tests are performed.
This is interesting because recent research into why APOE4 also increases the risk of Alzheimer’s disease indicate that APOE4 is involved in the immune system.
“An important limitation of the current paper is that this type of observational study cannot prove that the APOE4 gene is the cause of the observed increased risk of COVID-19.
The scientists did a thorough job of trying to control for other things associated with APOE4 that could account for the risk,
but it is still possible that there is an unknown related factor causing the increased risk.”
...
Prof Clive Ballard, Medical School Pro-Vice-Chancellor, University of Exeter, said:
“The E4 gene is a major risk gene for Alzheimer’s disease – people with one copy are at 3-4 fold increased risk and people with two copies have at least a 10 fold increased risk.
The current findings may partly explain why people with dementia are more at risk of severe COVID, and we should be taking more care of this vulnerable group of individuals at this challenging time”
“The implications of the study are well beyond the significant implications for people with dementia.
25% of people in the population carry one E4 gene, and this is clearly an important risk factor for developing severe COVID.
ApoE4 plays a major role in lipid and cholesterol metabolism and also has some role in immune response.
This may give us important clues in helping to develop new approaches to reduce risk.”